• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Novartis ’ Spinal Drug Gets FDA Approval, $2 Million Price Tag
(CNN) — The US Food and Drug Administration approved a treatment Friday for a genetic disease called spinal muscular atrophy that causes infants’ muscles to waste away, potentially killing them before age 2. And then came the price tag: $2.125 million for a one-time treatment. The gene therapy, called Zolgensma, will be marketed by AveXis, whose parent company is Novartis. “Today’s approval marks another milestone in the transformational power of gene and cell therapies to treat a wide range of diseases,” Dr. Ned Sharpless, the FDA’s acting commissioner, said in a statement Friday. ̶...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 24, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN Novartis Source Type: news

Neanderthal DNA May Play Role in Modern Human Health
Genetic legacy can affect risk for nicotine addiction, depression, blood clots and stroke, research suggests Source: HealthDay Related MedlinePlus Page: Genes and Gene Therapy
Source: MedlinePlus Health News - February 11, 2016 Category: Consumer Health News Source Type: news

'Longevity Gene' One Key to Long Life, Research Suggests
As 'good' cholesterol goes up, odds of heart disease, stroke go down Source: HealthDay Related MedlinePlus Pages: Cholesterol, Genes and Gene Therapy, Seniors' Health
Source: MedlinePlus Health News - November 6, 2014 Category: Consumer Health News Source Type: news

Targeted brain stimulation 'could aid stroke recovery'
Conclusion This mouse model of stroke has found that stimulating nerve cells in the part of the brain responsible for movement (the primary motor cortex) can lead to better blood flow and the expression of proteins that could promote recovery, as well as leading to functional recovery after stroke. But it remains to be determined whether a similar technique could be used in people who have had a stroke. The mice were genetically modified so nerve cells in the primary motor cortex produced an ion channel that could be activated by light. The nerve cells were then activated using a laser. To use this technique in humans, ...
Source: NHS News Feed - August 19, 2014 Category: Consumer Health News Tags: Neurology Source Type: news

Mediterranean Diet May Counter Genetic Risk of Stroke
People who consumed plenty of nuts or olive oil fared better in study Source: HealthDay Related MedlinePlus Pages: Diets, Genes and Gene Therapy, Stroke
Source: MedlinePlus Health News - August 13, 2013 Category: Consumer Health News Source Type: news